Europe Antibiotics Market, By Drug Class; By Type; By Action Mechanism; By Country, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

List of Tables

Europe Antibiotics Market Size at Steady 2.8% CAGR to Surpass USD 14 Billion by 2030

Europe Antibiotics Market is booming primarily due to the escalating prevalence of infectious diseases, an aging population, and improved diagnostic capabilities.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Europe Antibiotics Market size by value at USD 12 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Europe Antibiotics Market size to grow at a steady CAGR of 2.8% reaching a value of USD 14.4 billion by 2030. The Antibiotics Market in Europe is propelled by the escalating global health burden of infectious diseases. It is evident in the alarming surge of 4,500 hepatitis A cases in Europe in 2022 and the annual toll of 65,000 lives lost to antimicrobial-resistant bacterial infections. The market is further propelled by the expansion of established antibiotic products, strategic partnerships for novel antibiotic introductions, and substantial R&D investments by pharmaceutical giants like AbbVie, Pfizer, and Merck. The prevalence of chronic conditions, such as COPD, affecting over 36 million Europeans in 2020, exacerbates the demand for antibiotics. The ongoing innovation in infectious disease treatments, coupled with the urgent need to combat antimicrobial resistance, presents significant growth opportunities. Furthermore, the COVID-19 pandemic accelerated antibiotic usage, particularly for treating bacterial infections in COVID-19 patients, providing a further boost to the expansion of Europe Antibiotics Market.

France Holds Major Market Share in Europe Antibiotics Market

France continues to hold the largest share of the Europe Antibiotics Market, primarily attributed to a high demand for outpatient prescriptions. The country's dominance in the market is expected to persist over the forecast period. While significant efforts are underway to address the growing concern of antimicrobial resistance, antibiotic usage in outpatient settings remains elevated. A 2022 study by the National Center for Biotechnology Information (NCBI) highlights this trend, ranking France as the fourth-largest consumer of antibiotics in outpatient settings in 2019. With a consumption rate of over 23.0 defined daily doses (DDD) per 1,000 people daily, France surpasses the European average by more than 25%.

Impact of Escalating Geopolitical Tensions on Europe Antibiotics Market

Intensifying geopolitical tensions could have a multifaceted impact on Europe Antibiotics Market. Disruptions in global supply chains, particularly those reliant on key API suppliers from major global producers located in China and India, could lead to shortages and price increases. Moreover, geopolitical uncertainties may hinder international collaborations in research and development, slowing innovations and limiting access to essential antibiotics. It, in turn, could exacerbate the growing threat of antimicrobial resistance.

Competitive Landscape

Europe Antibiotics Market is highly fragmented, with numerous players serving the market. Major companies dominating the market include Novartis, GlaxoSmithKline (GSK), Pfizer, Bayer, Sanofi, Roche, Teva Pharmaceutical Industries, Stada Arzneimittel, Menarini Group, and Recordati. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge over their competitors in Europe Antibiotics Market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and Europe Antibiotics Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Europe Antibiotics Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24938

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Europe Antibiotics Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Rising prevalence of infectious diseases
  - 3.2.1.2. Growing aging population
  - 3.2.1.3. Increased awareness and diagnosis rates
- 3.2.2. Restraints
  - 3.2.2.1. Rise of multi-drug-resistant bacteria
  - 3.2.2.2. Strict EU regulations on antibiotic development and commercialization
  - 3.2.2.3. Overuse and misuse of antibiotics
- 3.2.3. Opportunities
  - 3.2.3.1. Growing investments in antimicrobial resistance (AMR) research
  - 3.2.3.2. Advancements in sustained-release formulations and targeted therapies
  - 3.2.3.3. Advancements in antibiotics development
- 3.2.4. Challenges
  - 3.2.4.1. High R&D costs
  - 3.2.4.2. Public health campaigns
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Europe Antibiotics Market: Marketing Strategies

5. Europe Antibiotics Market Overview

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
- 5.2.1. By Drug Class
  - 5.2.1.1. Cephalosporin
  - 5.2.1.2. Penicillin
  - 5.2.1.3. Fluoroquinolone
  - 5.2.1.4. Macrolides
  - 5.2.1.5. Carbapenems
  - 5.2.1.6. Aminoglycosides
  - 5.2.1.7. Sulfonamides
  - 5.2.1.8. 7-ACA
  - 5.2.1.9. Others
- 5.2.2. By Type
  - 5.2.2.1. Branded Antibiotics
  - 5.2.2.2. Generic Antibiotics
- 5.2.3. By Action Mechanism
  - 5.2.3.1. Cell Wall Synthesis Inhibitors
  - 5.2.3.2. Protein Synthesis Inhibitors
  - 5.2.3.3. DNA Synthesis Inhibitors
  - 5.2.3.4. RNA Synthesis Inhibitors
  - 5.2.3.5. Mycolic Acid Inhibitors
  - 5.2.3.6. Others
- 5.2.4. By Country
  - 5.2.4.1. Germany
  - 5.2.4.2. United Kingdom
  - 5.2.4.3. Italy
  - 5.2.4.4. France
  - 5.2.4.5. Spain
  - 5.2.4.6. Belgium
  - 5.2.4.7. Russia
  - 5.2.4.8. The Netherlands
  - 5.2.4.9. Rest of Europe

6. Germany Antibiotics Market

6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
- 6.2.1. By Drug Class
- 6.2.2. By Type
- 6.2.3. By Action Mechanism

7. United Kingdom Antibiotics Market

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
- 7.2.1. By Drug Class
- 7.2.2. By Type
- 7.2.3. By Action Mechanism

8. Italy Antibiotics Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
- 8.2.1. By Drug Class
- 8.2.2. By Type
- 8.2.3. By Action Mechanism

9. France Antibiotics Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
- 9.2.1. By Drug Class
- 9.2.2. By Type
- 9.2.3. By Action Mechanism

10. Spain Antibiotics Market

10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
- 10.2.1. By Drug Class
- 10.2.2. By Type
- 10.2.3. By Action Mechanism

11. Belgium Antibiotics Market

11.1. Market Size & Forecast, 2019-2030
- 11.1.1. By Value (USD Billion)
11.2. Market Share & Forecast
- 11.2.1. By Drug Class
- 11.2.2. By Type
- 11.2.3. By Action Mechanism

12. Russia Antibiotics Market

12.1. Market Size & Forecast, 2019-2030
- 12.1.1. By Value (USD Billion)
12.2. Market Share & Forecast
- 12.2.1. By Drug Class
- 12.2.2. By Type
- 12.2.3. By Action Mechanism

13. The Netherlands Antibiotics Market

13.1. Market Size & Forecast, 2019-2030
- 13.1.1. By Value (USD Billion)
13.2. Market Share & Forecast
- 13.2.1. By Drug Class
- 13.2.2. By Type
- 13.2.3. By Action Mechanism

14. Rest of Europe Antibiotics Market

14.1. Market Size & Forecast, 2019-2030
- 14.1.1. By Value (USD Billion)
14.2. Market Share & Forecast
- 14.2.1. By Drug Class
- 14.2.2. By Type
- 14.2.3. By Action Mechanism

15. Competitive Landscape

15.1. List of Key Players and Their Offerings
15.2. Europe Antibiotics Company Market Share Analysis, 2023
15.3. Competitive Benchmarking, By Operating Parameters
15.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

16. Impact of Escalating Geopolitical Tensions on Europe Antibiotics Market

17. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

17.1. Novartis
17.2. GlaxoSmithKline (GSK)
17.3. Pfizer
17.4. Bayer
17.5. Sanofi
17.6. Roche
17.7. Teva Pharmaceutical Industries
17.8. Stada Arzneimittel
17.9. Menarini Group
17.10. Recordati
17.11. Other Prominent Players

18. Key Strategic Recommendations

19. Research Methodology

19.1. Qualitative Research
- 19.1.1. Primary & Secondary Research
19.2. Quantitative Research
19.3. Market Breakdown & Data Triangulation
- 19.3.1. Secondary Research
- 19.3.2. Primary Research
19.4. Breakdown of Primary Research Respondents, By Country
19.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

Product Code: BWC24938

List of Figures

Figure 1 Europe Antibiotics Segmentation
Figure 2 Europe Antibiotics Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Europe Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 5 Europe Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 6 Europe Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 7 Europe Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 8 Europe Antibiotics Market Share, By Country, By Value, 2019-2030
Figure 9 Germany Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 10 Germany Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 11 Germany Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 12 Germany Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 13 United Kingdom Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 14 United Kingdom Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 15 United Kingdom Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 16 United Kingdom Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 17 Italy Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 18 Italy Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 19 Italy Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 20 Italy Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 21 France Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 22 France Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 23 France Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 24 France Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 25 Spain Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 26 Spain Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 27 Spain Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 28 Spain Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 29 Belgium Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 30 Belgium Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 31 Belgium Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 32 Belgium Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 33 Russia Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 34 Russia Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 35 Russia Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 36 Russia Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 37 The Netherlands Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 38 The Netherlands Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 39 The Netherlands Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 40 The Netherlands Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030
Figure 41 Rest of Europe Antibiotics Market Size, By Value (USD Billion), 2019-2030
Figure 42 Rest of Europe Antibiotics Market Share, By Drug Class, By Value, 2019-2030
Figure 43 Rest of Europe Antibiotics Market Share, By Type, By Value, 2019-2030
Figure 44 Rest of Europe Antibiotics Market Share, By Action Mechanism, By Value, 2019-2030

List of Tables

Table 1 Europe Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 2 Europe Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 3 Europe Antibiotics Market Size, By Type, By Value, 2019-2030
Table 4 Europe Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 5 Europe Antibiotics Market Size, By Country, By Value, 2019-2030
Table 6 Germany Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 7 Germany Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 8 Germany Antibiotics Market Size, By Type, By Value, 2019-2030
Table 9 Germany Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 10 United Kingdom Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 11 United Kingdom Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 12 United Kingdom Antibiotics Market Size, By Type, By Value, 2019-2030
Table 13 United Kingdom Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 14 Italy Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 15 Italy Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 16 Italy Antibiotics Market Size, By Type, By Value, 2019-2030
Table 17 Italy Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 18 France Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 19 France Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 20 France Antibiotics Market Size, By Type, By Value, 2019-2030
Table 21 France Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 22 Spain Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 23 Spain Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 24 Spain Antibiotics Market Size, By Type, By Value, 2019-2030
Table 25 Spain Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 26 Belgium Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 27 Belgium Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 28 Belgium Antibiotics Market Size, By Type, By Value, 2019-2030
Table 29 Belgium Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 30 Russia Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 31 Russia Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 32 Russia Antibiotics Market Size, By Type, By Value, 2019-2030
Table 33 Russia Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 34 The Netherlands Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 35 The Netherlands Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 36 The Netherlands Antibiotics Market Size, By Type, By Value, 2019-2030
Table 37 The Netherlands Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 38 Rest of Europe Antibiotics Market Size, By Value (USD Billion), 2019-2030
Table 39 Rest of Europe Antibiotics Market Size, By Drug Class, By Value, 2019-2030
Table 40 Rest of Europe Antibiotics Market Size, By Type, By Value, 2019-2030
Table 41 Rest of Europe Antibiotics Market Size, By Action Mechanism, By Value, 2019-2030
Table 42 Novartis Company Overview
Table 43 Novartis Financial Overview
Table 44 GlaxoSmithKline (GSK) Company Overview
Table 45 GlaxoSmithKline (GSK) Financial Overview
Table 46 Pfizer Company Overview
Table 47 Pfizer Financial Overview
Table 48 Bayer Company Overview
Table 49 Bayer Financial Overview
Table 50 Sanofi Company Overview
Table 51 Sanofi Financial Overview
Table 52 Roche Company Overview
Table 53 Roche Financial Overview
Table 54 Teva Pharmaceutical Industries Company Overview
Table 55 Teva Pharmaceutical Industries Financial Overview
Table 56 Stada Arzneimittel Company Overview
Table 57 Stada Arzneimittel Financial Overview
Table 58 Menarini Group Company Overview
Table 59 Menarini Group Financial Overview
Table 60 Recordati Company Overview
Table 61 Recordati Financial Overview

Europe Antibiotics Market, By Drug Class; By Type; By Action Mechanism; By Country, Trend Analysis, Competitive Landscape & Forecast, 2019-2030

Description

Table of Contents

List of Tables

Table of Contents

1. Research Framework

2. Executive Summary

3. Europe Antibiotics Market Insights

4. Europe Antibiotics Market: Marketing Strategies

5. Europe Antibiotics Market Overview

6. Germany Antibiotics Market

7. United Kingdom Antibiotics Market

8. Italy Antibiotics Market

9. France Antibiotics Market

10. Spain Antibiotics Market

11. Belgium Antibiotics Market

12. Russia Antibiotics Market

13. The Netherlands Antibiotics Market

14. Rest of Europe Antibiotics Market

15. Competitive Landscape

16. Impact of Escalating Geopolitical Tensions on Europe Antibiotics Market

17. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

18. Key Strategic Recommendations

19. Research Methodology

List of Figures

List of Tables